The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Exome analysis of oncogenic pathways and tumor mutational burden (TMB) in triple-negative breast cancer (TNBC): Results of the translational biomarker program of the neoadjuvant double-blind placebo controlled GeparNuevo trial.
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Bruno Valentin Sinn
No Relationships to Disclose
 
Thomas Karn
No Relationships to Disclose
 
Michael Untch
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai Germany; Lilly; Merck Sharp & Dohme; Mundipharma; Myriad Genetics; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mundipharma (Inst); Odonate Therapeutics; Odonate Therapeutics; Pfizer (Inst); Puma Biotechnology; Roche Pharma AG (Inst)
 
Hans-Peter Sinn
Honoraria - Roche
Consulting or Advisory Role - Genomic Health
Research Funding - Roche
Travel, Accommodations, Expenses - Roche
 
Karsten Ernst Weber
Patents, Royalties, Other Intellectual Property - Myriad Genetics
 
Claus Hanusch
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche
Speakers' Bureau - Celgene; Lilly; Novartis; Pfizer; Roche
 
Jens Bodo Huober
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Novartis; Pfizer; Roche
 
Peter Staib
Honoraria - Abbvie; Amgen; Celgene; Janssen-Cilag; Roche
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag
Speakers' Bureau - Abbvie; Amgen; Celgene
Research Funding - Celgene; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Pfizer; Roche; SERVIER
 
Ralf Lorenz
Honoraria - AstraZeneca; Axios; GlaxoSmithKline; Novartis; Oncovir; Roche
 
Jens Uwe Blohmer
Honoraria - Amgen; AstraZeneca; Genomic Health; MSD Oncology; Myriad Genetics; Novartis/Pfizer; Pfizer; Roche; Sonoscape
Travel, Accommodations, Expenses - Pfizer; Roche
 
Frederik Marmé
Honoraria - AstraZeneca; Celgene; Clovis Oncology; Eisai; Genomic Health; MSD; Pfizer; Roche; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca; CureVac; Eisai; MSD; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Pfizer; PharmaMar; Roche
 
Wolfgang D Schmitt
Honoraria - AstraZeneca
 
Kerstin Rhiem
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Marion van Mackelenbergh
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Novartis
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Novartis (Inst)
 
Song Wu
No Relationships to Disclose
 
Brandon W. Higgs
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; MSD; Novartis; Pfizer; Roche; Teva
Patents, Royalties, Other Intellectual Property - EP18209672
Other Relationship - VMscope